Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Biochem Pharmacol. 2019 May 8;167:3–12. doi: 10.1016/j.bcp.2019.05.006

Table 2.

A summary of PARdU substrates, their associated biological processes and possible pathological outcomes upon PARdU dysregulation.

PARdU substrate Biological Pathway Pathology
Axin1/2 Wnt signaling Cancer
3BP2 SRC, SYK, VAV signaling Cherubism
PTEN AKT signaling; tumor suppressor Cancer
AMOTL2 Tight junctions Cancer
PARP1 DNA damage, stress response Cancer